|
|
 |
|
Organization |
|
---------------------------------- |
|
|
|
| |
Support Organization |
|
|
Partners |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
| |
Full Scientific Program |
Theme: Combating Severe Viral Infections |
Time: July 20-22, 2008
Place: Empark Grand Hotel(EGH), Kunming,China |
| ¡¡ |
Tech Tour |
Time: July 23-26, 2008
Place: Lijiang & Shangri-La, Yunan, China |
| The scientific program for the conference is under development by selecting hot topics for oral presentations and technological summary for posters. Poster sessions will be held through the whole summit. |
| |
July 19, 2008
Time |
Lobby of Empark Grand Hotel Kunming |
8:00-20:00 |
Registration |
|
| |
| July 20-22, 2008 |
| ¡¡ |
Opening Ceremony and Keynote Forum
(Time: 09:00-11:30 July 20, 2008, Sunday Place: International Hall, 3F) |
08:15-08:30 |
Group Photo in front of the Hotel |
09:00-09:30 |
Opening Ceremony |
Keynote & Plenary Lectures
|
Host: |
Dr. Shibo Jiang, Head, Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, USA |
09:30-10:10 |
 |
Title: HIV/AIDS Research: Perspectives from the Past and Prospects for the Future
Dr. Robert C. Gallo, Director, Institute of Human Virology University of Maryland, USA |
10:10-10:50 |
 |
Title: Infectious Agents in the Causation of Human Cancers
Dr. Harald zur Hausen, Professor Emeritus, German Cancer Research Institute, Germany |
10:50-11:30 |
 |
Title: HIV /AIDS in China-A Potential Epidemic?
Dr. Konglai Zhang, Professor, Chinese Academy of Medical Science and Peking Union Medical College, China |
11:30-13:00 |
Luncheon |
|
|
Track 1: Public Health and Basic Sciences for Emerging and Major Viral Infectious Diseases
Session 1: Global Plans and Multi-Lateral Cooperative for Responding to Emerging and Re-Emerging Viral Infectious Diseases
(Time: 13:30-17:45 July 20, 2008, Sunday Place: VIP Conference Room 1, 3F) |
Session Chair:
|
Dr. Sanjib Bhattacharyya, Chief Molecular Scientist and Principal Investigator, Select Agent Program for Bioterrorism Preparedness & Response, City of Milwaukee Health Department,USA |
Co-Chair: |
Dr. A K Prasad, Chairman, Influenza Foundation of India, India |
13:30-13:35 |
Session Introduction |
|
13:35-14:00 |
 |
Title: Eradication of Helminthic Infections May be Essential for Successful Vaccination Against HIV in Most Developing Countries
Dr. Gadi Borkow, Chief Medical Scientist, Cupron Inc., USA |
14:00-14:25 |
 |
Title: Pandemic Preparedness: Community Approach Model for Strengthening National and Global Response Plan to Combat Viral Infections
Dr. Sanjib Bhattacharyya, Chief Molecular Scientist and Principal Investigator, Select Agent Program for Bioterrorism Preparedness & Response, City of Milwaukee Health Department,USA |
14:25-14:50 |
 |
Title: Risk Assessment of Emerging Flaviviruses: High Flavivirus Antibody Prevalence in Wild Ducks Captured in Hokkaido, Japan
Dr. Mika Saito, Instructor, Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, Japan |
14:50-15:15 |
 |
Title: HIV Vaccine Preparedness Studies in the Non-Organization for Economic Co-Operation and Development (Non-OECD) Countries
Dr. Shayesta Dhalla, Physician, Department of Health Care and Epidemiology, University of British Columbia, Canada |
15:15-15:30 |
Tea Break |
15:30-15:55 |
 |
Title: Human Influenza Pandemic in Waiting
Dr. A K Prasad, Chairman, Influenza Foundation of India, India |
15:55-16:20 |
 |
Title: Collateral Effects of Antiviral Drugs - an Important Problem for the Medical Practice
Dr. Mihai Nechifor, President, Romanian Society for the Study of Chemotherapeutics, Romania |
16:20-16:45 |
 |
Title: New Emerging Viruses: Group-Specific Antivirals would be the Answer
Dr. Claude P. Muller, Director, Institute of Immunology, National Public Health Laboratory, Luxembourg |
16:45-17:10 |
 |
Title: What to Target to Control the HIV Infection in South Africa?
Dr. Banwari Meel, Professor and Head, Department of Forensic Medicine and Toxicology, Walter Sisulu University, South Africa |
17:10-17:35 |
 |
Title: Distribution Strategies of the Limited Amounts of Antiviral Medicine and Vaccines in a Context of Pandemic Influenza. Simulation Studies Using Global Epidemic Model (GEM)
Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA |
17:35-17:45 |
Discussion |
|
Session 2: Etiology and Epidemiology of Viral Infections
(Time: 13:30-17:00 July 21, 2008, Monday Place: VIP Conference Room 1, 3F) |
| Session Chair: |
Dr. R. Palmer Beasley, Director, Center for International Training and Research (CITAR), University of Texas School of Public Health at Houston, USA |
| Co-Chair: |
Dr. Reinhard Kurth, Professor, Robert Koch Institute, Germany |
| 13:30-13:35
|
Session Introduction |
| 13:35-14:05 |
 |
Keynote Speech:
Title: The Renaissance of Infectious Diseases as a Consequence of Human Behavior
Dr. Reinhard Kurth, Professor, President of the Robert Koch Institute, Germany |
| 14:05-14:35 |
 |
Title: Chronic Fatigue Syndrome Research in Latvia 2002-2007
Dr. Ludmila Viksna, Chief of Infectology Chair, Riga Stradins University, Latvia |
14:35-15:05 |
 |
Title: Discovery of and Mechanistic Insight into Activation by Dioxin-Type Xenobiotics of Cancer- Linked Common Human Viruses and HIV-1 Virus
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc.,USA |
| 15:05-15:20 |
Tea Break |
| 15:20-15:50 |
 |
Title: Epidemiology and Clinical Outcomes of HBV Infection
Dr. Prapan Jutavijittum, Associate Professor, Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand |
| 15:50-16:20 |
|
Title: Spectral Analysis of HIV Seropositivity among Migrant Workers Entering Kuwait
Dr. Saeed Akhtar, Associate Professor, Faculty of Medicine, Kuwait University, Kuwait |
| 16:20-17:00 |
Discussion |
|
Session 3: Epidemiology and Virology
(Time: 08:30-09:35 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F) |
Session Chair:
|
Dr. Lu-Yu Hwang, Professor, Epidemiology / Disease Control, Director, Laboratory of Virology/ STDs Research, Center for Infections Diseases (CID), Associate Director, Center for International Training & Research (CITAR), University of Texas, School of Public Health at Houston , Texas, USA |
08:30-08:35 |
Session Introduction |
08:35-09:05 |
|
Title: Measles Control in Guangxi, China: High Risk County Selection and its Campaign Strategy
Dr. Jiatong Zhuo, Deputy Director, Guangxi CDC, China |
09:05-09:35 |
|
Title: Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States
Dr. Lu-Yu Hwang, Professor, Epidemiology / Disease Control, Director, Laboratory of Virology/STDs Research, Center for Infections Diseases (CID), Associate Director, Center for International Training & Research (CITAR), University of Texas School of Public Health at Houston, Texas, USA |
|
Session 4: Informatics, Biostatistics and Mathematical Modeling for Antiviral Researches
(Time: 09:40-11:00 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F) |
Session Chair:
|
Dr. Paolo Carloni,
Full Professor, International School for Advanced Studies (SISSA/ISAS), Italy |
| Co-Chair: |
Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA |
|
09:40-9:45
|
Session Introduction
|
|
09:45-10:10 |
 |
Title: Clinical Characteristics and Treatments on Cytomegalovirus Retinitis Associated with AIDS in Shanghai
Dr. Ying Shi, Director, Shanghai Public Health Clinical Center Affiliated to Fudan University,China |
|
10:10-10:35 |
|
Title: Macromolecular Aggregates Containing HIV-1 Proteins Investigated by Computational Methods
Dr. Paolo Carloni, Full Professor, International School for Advanced Studies (SISSA/ISAS), Italy |
10:35-11:00 |
|
Title: Distribution Strategies of the Limited Amounts of Antiviral Medicine and Vaccines in a Context of Pandemic Influenza. Simulation Studies Using Global Epidemic Model (GEM)
Dr. Georgiy Bobashev, Senior Research Statistician, RTI International, USA |
|
Track 2: Major Antiviral Drug Discovery and Development
Session 5: Targets of Respiratory Viruses Infection and the Corresponding Antiviral Therapeutics
(Time:13:30-15:50 July 22, 2008, Tuesday Place: VIP Conference Room 1, 3F ) |
| Session Chair: |
Dr. Yhu-Chering Huang,Chief ,Pediatric Research Center, Chang Gung Children's Hospital, Taiwan |
13:30-13:35 |
Session Introduction |
13:35-14:05 |
|
Title: Implementing a Community Based Tuberculosis Management Program in Namibia
Dr. Valerie Janet Ehlers, Professor, Department of Health Studies, University of South Africa, South Africa |
14:05-14:35 |
|
Title: Inhibition of SARS Virus Entry by Medicinal Herbs
Dr. Toshio Hattori, Professor, Div Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Japan |
14:35-15:05 |
|
Title: Influenza-Associated Central Nervous System Dysfunction in Taiwanese Children and Young Adolescents: Clinical Characteristics and Outcomes with and without Exposure to Oseltamivir
Dr. Yhu-Chering Huang, Chief, Pediatric Research Center, Chang Gung Children's Hospital, Taiwan |
15:05-15:35 |
|
Title: Infectivity of Elderly Humans by Avian Influenza Virus (AIV)
Dr. Julia Albright, Senior Technical Advisor, International Relief & Development, Inc., USA |
15:35-15:50 |
Tea Break & Discussion |
|
Session 6: Omics and System Biology for Viral Infectious Diseases
(Time: 13:30-16:05 July 20, 2008, Sunday Place: VIP Conference Room 3, 3F ) |
| Session Chair: |
Dr. Xiaohua (Douglas) Zhang, Associate Director, Biometrics Research, Merck Research Laboratories, USA |
| Co-Chair: |
Dr. Bing Sun,
Co-Director, Institute Pasteur of
Shanghai, Chinese Academy of Sciences,
China |
|
13:30-13:35
|
Session Introduction |
|
13:35-14:00 |
 |
Title: Human Coronavirus SNE Protein Regulates Virus Assembly and Release via Activation of Endogenous L-type Calcium Channel
Dr. Bing Sun, Co-Director, Institute Pasteur of Shanghai, Chinese Academy of Sciences, China |
|
14:00-14:25 |
 |
Title: Analytic Methods in Genome-Scale RNAi Research with Applications in Drug Discovery for Viral Infectious Diseases
Dr. Xiaohua (Douglas) Zhang, Associate Director, Biometrics Research, Merck Research Laboratories, USA |
14:25-14:50 |
|
Title: Transcription Factor Egr-1 Enhances the Infection and Virulence of HSV-1
Dr. Ching Li, Professor, Department of Microbiology and Immunology, National Chiayi University, Taiwan |
|
14:50-15:15 |
 |
Title: Finding Signatures for Response to IFN Treatment in Chronic Hepatitis C Virus Patients with Genotype 1a, 1b, and 3a: a Multi Bioinformatics Approach
Dr. Mahmoud M. ElHefnawi, Researcher, Department of Medical Biotechnology, Division of Genetic Engineering and Biotechnology, National Research Centre, Egypt |
|
15:15-15:40 |
|
Title: Using Genetic Approach to Identify Herpesvirus Pathogenic Genes
Dr. Hua Zhu, Associate Professor, UMDNJ-New Jersey Medical School, USA |
|
15:40-16:05 |
|
Title: Functional Switch of Dendritic Cells during Chronic Hepatitis C Virus Infection
Dr. Li Zhao, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada |
|
Workshop: Career Development-Research Opportunities for Young Scientists
(Time: 16:05-16:45 July 20, 2008, Sunday Place: VIP Conference Room 3, 3F ) |
|
16:05-16:45 |
|
Title: Career in Biostatistics
Dr. Misrak Gezmu, Mathematical Statistician, NIH, NIAID, DCR, BRB, USA |
|
Session 7: Upstream Platform Technologies for Antiviral Drug Discovery
(Time: 08:30-12:00 July 21, 2008, Monday Place: VIP Conference Room 1, 3F) |
| Session Chair: |
Dr. Tetsuya Toyoda, Professor, Principal Investigator, Unit of Viral Genome Regulation, Institute Pasteur of Shanghai, Chinese Academy of Sciences, China |
| Co-Chair: |
Dr. Qianjun Li, Research Scientist, Drug Discovery, Southern Research Institute, USA |
08:30-08:35 |
Session Introduction |
08:35-09:05 |
|
Keynote Speech:
Title: Arbovirus and Relative Disease in Mainland China
Dr. Guodong Liang, Professor, Department of Viral Encephalitis and Arbovirus, Institute for Viral Disease Control and Prevention, China CDC, China |
09:05-09:35 |
 |
Title: Developing a Novel High-Throughput Screening Assay against Arboviruses
Dr. Qianjun Li, Research Scientist, Drug Discovery, Southern Research Institute, USA |
09:35-10:05 |
|
Title: Elucidation of Host Factors Involved in Replication of Hepatitis C Virus
Dr. Kunitada Shimotohno, Professor, Research Institute, Chiba Institute of technology, Japan |
10:05-10:20 |
Tea Break |
10:20-10:50 |
|
Title: In Vitro Transcription System for Drug Screening and Evaluation of Polymerase Inhibitors.
Dr. Tetsuya Toyoda, Professor, Principal Investigator, Unit of Viral Genome Regulation Institute Pasteur of Shanghai, Chinese Academy of Sciences, China |
10:50-11:20 |
 |
Title: Efficient Functional Protein Selection Based on Ribosome Display Technology
Dr. Xiao-Ling Zhao, Associate Professor, Institute of Health and Enviramental Medicine, Academy of Military Medical Sceience, China |
11:20-11:50 |
|
Title: New Druggable Targets, Novel Anti-Flu Agents
Dr. Richard Y.T. Kao, Director, Chemical Genetics Unit, Center of Infection and Immunology, Assistant Professor, Department of Microbiology, LKS Faculty of Medicine, the University of Hong Kong, China |
11:5 -12:00 |
Discussion |
|
Session 8: Frontier of Gene and Cell Therapy for Viral Infectious Diseases
(Time: 13:30-15:40 July 21, 2008, Monday Place: VIP Conference Room 3, 3F) |
Session Chair:
|
Dr. Jiann-Ruey Hong,
Assistant Professor, Institute of
Biotechnology, National Cheng Kung
University |
| Co-Chair: |
Dr. Xiaojian Yao,
Assistant Professor, University of
Manitoba, Canada |
|
13:30-13:35
|
Session Introduction |
|
13:35-14:00 |
 |
Title: Overcoming HIV-1 Vif's Blockage and Inhibiting Viral Replication by an Apobec 3G Fusion Protein
Dr. Xiaojian Yao, Assistant Professor, University of Manitoba, Canada |
|
14:00-14:25 |
|
Title: Protein-Based Strategies for Nucleic Acid Delivery: A Tale of Two TAT Chimeras
Dr. Vijaya Gopal, Assistant Director, Centre for Cellular and Molecular Biology, India |
14:25-14:50 |
 |
Title: Knockdown of Betanodavirus Viral Necrotic Genes with siRNA Approach
Dr. Jiann-Ruey Hong, Assistant Professor, Institute of Biotechnology, National Cheng Kung University |
|
14:50-15:15 |
|
Title: Side ET Toxicomanie
Dr. Abdelmajid ZAHAF, President, ATLMST/SIDA-Tunisian Association for STD/AIDS, Tunisian Association for the Prevention of Drug-abuse, Tunis |
| 15:15-15:40 |
|
Title: Effects of Nanomodified Antisense Oligodeoxynucleotides on HIV Viral Replication
Dr. Hsiao-Nan Hao, Assistant Professor, Wayne State University, School of Medicine, USA |
|
Session 9: Structure Based Antiviral Drug Design and Synthesis
(Time: 08:30-11:30 July 22, 2008, Tuesday Place: VIP Conference Room 3, 3F) |
Session Chair:
|
Dr. Hong Zhou, Professor & Director, Department of Microbiology and Electron Imaging Center for Nanomachines, UCLA, USA |
08:30-08:35 |
Session Introduction |
08:35-09:00 |
|
Title: Discovery of Inhibitors Targeting Wild Type and Mutant M2 Channels of Influenza A
Dr. Guo-Chun Zhou, Investigator, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China |
09:00-09:25 |
|
Title: Nucleocapsid Protein NP as a Target for Inhibition of Flu Virus Replication
Dr. Ming-Daw Tsai,Distinguished Research Fellow, Genomics Research Center, Acting Director, Institute of Biological Chemistry, Academia Sinica, Taiwan |
09:25-09:50 |
|
Title: CryoEM Structural Studies of Tumor Herpesviruses and Potential for Structure-Guided Drug Target Identification
Dr. Hong Zhou, Professor& Director, Department of Microbiology and Electron Imaging Center for Nanomachines, UCLA, USA |
09:50-10:15 |
|
Title: Novel HIV-1 Attachment Inhibitor(s) Derived From Peptides of the Leukocyte Surface Antigen CD38
Dr. Andrea Savarino, Researcher, Italian Institute of Health,Italy |
10:15-10:30 |
Tea Break |
10:30-10:55 |
|
Title: Design, Synthesis and Preliminary Activity Assay of Influenza Virus Neuraminidase Inhibitors
Dr. Wen-Fang Xu, Professor, Department of Medicinal Chemistry, Shandong University, China |
10:55-11:20 |
|
Title: A Proposal of the Way to Develop Highly Active and Lowly Toxic Antiviral Modified Nucleosides
Dr. Hiroshi Ohrui, Professor, Yokohama College of Pharmacy, Japan |
11:20-11:30 |
Discussion |
|
Session 10: Drug Discovery and Development on Major Emerging/Re-emerging Viral Diseases
(Time: 13:30-17:20 July 22, 2008, Tuesday Place: VIP Conference Room 3, 3F ) |
| Session Chair: |
Dr. Girish J. Kotwal, Professor,
Kotwal Bioconsulting, USA |
| Co-Chair: |
Dr. Yanjie Sun, Research Scientist, Drug Discovery Division, Southern Research Institute, USA |
13:30-13:35 |
Session Introduction |
13:35-14:00 |
|
Title: Adenosine Kinase is the Primary Enzyme for the Antiviral Activity of 1-¦Â-D- Ribofuranosyl-3-ethynyl-[1,2,4] Triazole (ETAR) against Hantavirus
Dr. Yanjie Sun, Research Scientist, Drug Discovery Division, Southern Research Institute, USA |
14:00-14:25 |
|
Title: Enveloped Virus Neutralizing Compounds (EVNCs) as Versatile Antivirals against Enveloped Viruses
Dr. Girish J. Kotwal, Professor, Kotwal Bioconsulting, USA |
14:25-14:50 |
|
Title: Anti-Herpetic Therapeutic: A New Approach to Treatment of Herpes Infection
Dr. Guna Feldmane, August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Latvia |
14:50-15:15 |
 |
Title: Secretory Small Molecule from Non-Pathogenic Oral Bacteria Up-Regulates APOBEC3 and Inhibits HIV-1 Replication
Dr. Bindong Liu, Assistant Professor, Meharry Medical College, Center for AIDS Health Disparities, USA |
15:15-15:30 |
Tea Break |
15:30-15:55 |
|
Title: New Agents for the Treatment of Viral Diseases: from Common Cold to Alphaviruses-Induced Arthitis
Dr. Caterina Maugeri, Researcher, Angelini Research Center,Italy |
15:55-16:20 |
|
Title: Newly Synthesized Ketonucleoside Derivatives are Promising Inhibitors of RNA and DNA Viruses
Dr. Avrelija Cencic, Professor, University of Maribor, Faculty of Agriculture and Faculty of Medicine, Slovenia |
16:20-16:45 |
 |
Title: Antiviral Activity of Hexose Glycosides Complex
Dr. Mikhail Gomberg, Director for Science, Chief Researcher, Federal Institute for Blood Substitutes and Pharmaceuticals, Russia |
16:45-17:10 |
 |
Title: Artificially Composed Herbal Extract in Cure of Hepatitis
Dr. Pauli Virtanen, Laboratory Manager and Vice Director, Turku University, Finland |
17:10-17:20 |
Discussion |
|
Session 11: Drug Targets for HBV and the Corresponding Antiviral Therapeutics
(Time: 13:30-17:10 July 20, 2008, Sunday Place: No.1 Conference Room, 3F ) |
Session Chair:
|
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc. ,USA |
| Co-Chair: |
Dr. Hong Zhang, Project Manager, Beijing Enlinor Pharmaceutical Technology Co. Ltd., China |
|
13:30-13:35
|
Session Introduction |
|
13:35-14:15 |
|
Keynote Speech:
Title: The Hepatitis B Virus: from Cloning to Vaccine
Dr. Pierre Tiollais, Professor, Nuclear Organization and Ontogenesis Unit, INSERM U579, Institute Pasteur, France |
|
14:15-14:45 |
|
Title: Hepatitis B Virus Replication Might be Upregulated by Human Body Burden Dioxin: Epidemiological Data and Therapeutic Approach
Dr. Ilya B.Tsyrlov, Chief Scientific Officer, XENOTOX Inc. , USA |
14:45-15:15 |
|
Title: HBV in Subsahran Africa and SE-Asia: New Subtypes, Multiple Double/Triple Recombinations, A new Genotype and Several Puzzles
Dr. Claude P. Muller, Director, Institute of Immunology, National Public Health Laboratory, Luxembourg |
|
15:15-15:30 |
Tea Break |
|
15:30-16:00 |
|
Title: MIV-210, A Promising Candidate Drug for Treating Hepatitis B Virus Infection
Dr. Hong Zhang, Project Manager, Beijing Enlinor Pharmaceutical Technology Co. Ltd., China |
|
16:00-16:30 |
|
Title: HBV Treatment: Actual Clinical Updates
Dr. Giorgio Barbarini, Chief, Outstanding Patients Department of Infectious and Tropical Diseases of Foundation IRCCS San Matteo University of Pavia, Italy |
|
16:30-17:00 |
 |
Title: Detection of HBV Lamivudine-Resistant Mutations and Genotypes by PCR-RFLP, Touch-Down Real-Time PCR and DHPLC Assay
Dr. Yanqin Lu, Associate Professor, Shandong Medicinal Biotechnology Centre, China |
|
17:00-17:10 |
Discussion |
|
Session 12: HCV Key Viral Proteins, Drug Targets and the Corresponding Antiviral Therapeutics
(Part I)
(Time: 08:30-11:30 July 21, 2008, Monday Place: VIP Conference Room 3, 3F ) |
| Session Chair: |
Dr. Thomas I. Michalak, Professor of Molecular Virology and Medicine, Senior Canada Research Chair in Viral Hepatitis/Immunology, Molecular Virology and Hepatology Research, Faculty of Medicine, Memorial University, Canada |
| Co-Chair: |
Dr. Hengli Tang, Assistant Professor, Florida State University, USA |
|
08:30-08:35
|
Session Introduction |
|
08:35-09:05 |
|
Keynote Speech:
Title: Novel Receptor and Small Molecule Inhibitors for HCV Entry
Dr. Flossie Wong-Staal, CSO, Executive Vice President Research, iTherX Pharmaceuticals, Inc., USA |
|
09:05-09:35 |
|
Title: Small Interfering RNAs Targeting an Essential Cellular Cofactor of HCV Polymerase as A Potential Anti-HCV Therapy
Dr. Hengli Tang, Assistant Professor, Florida State University, USA |
|
09:35-10:05 |
|
Title: Characterization of A Novel and Potent HCV Helicase Inhibitor
Dr. Zhuhui Huang, Project Leader, Hepatitis Research Program, Southern Research Institute, USA |
|
10:05-10:20 |
Tea Break
|
10:20-10:50 |
 |
Title: Occult Hepatitis C Virus and Hepatitis B Virus Infections: Identification, Clinical Consequences and Therapeutic Interventions
Dr. Thomas I. Michalak, Professor of Molecular Virology and Medicine, Senior Canada Research Chair in Viral Hepatitis/Immunology, Molecular Virology and Hepatology Research, Faculty of Medicine, Memorial University, Canada |
|
10:50-11:20 |
|
Title: Treatment of Hepatitis C after Liver Transplantation
Dr. Sandeep Mukherjee, Associate Professor of Internal Medicine, Nebraska Medical Center, Section of Gastroenterology and Hepatology, USA |
|
11:20-11:50 |
|
Title: Neutralizing the Hepatitis C Virus
Dr. Mats A. A. Persson, Karolinska Institutet, Stockholm, Sweden |
|
Session 13: HCV Key Viral Proteins, Drug Targets and the Corresponding Antiviral Therapeutics
(Part II)
(Time: 13:30-17:15 July 21, 2008, Monday Place: No.1 Conference Room, 3F) |
 |
Recent Clinical Trial Results with Host- and Specifically-Targeted Antiviral Therapies for HCV (STAT-C)
Vertex Co-organized and Sponsored Session |
Session Chair:
| | | | |
